Obesity influences the responsiveness of the microcirculation ; constriction is augmented probably reflecting heightened sympathetic nervous activity.
INTRODUCTION
Measurements of forearm blood flow and the responses of the microcirculation to vascular constrictors and dilators have provided valuable physiological and phar-is the wall to lumen ratio, which occurs with disorders such as hypertension, is a further factor [1] . Forearm blood flow measured by venous occlusion plethysmography has been interpreted as a potential surrogate for the coronary circulation, since both respond similarly, for instance, to lowering plasma cholesterol levels [2] [3] [4] [5] .
Sympathetic nerve discharge to vasculature in skeletal muscle is increased in obesity and diminishes with weight reduction [6, 7] . Forearm vascular resistance in obese adolescents has been reported to be raised and correlates with indices of insulin resistance [8] . Central body fatness itself is associated with increased plasma noradrenaline appearance rate [9] , and the waist\thigh ratio, an index of central or visceral adiposity, has been found to correlate with increased sympathetic neuronal activity as measured by microneurography [10] .
Less clear are the relative contributions of increased vascular constriction versus impaired vasodilatation, to the reported heightened vascular resistance in obese people. Nor has the raised noradrenaline spillover rate reported in obesity been examined in relation to the capacity of resistance vessels to dilate.
We therefore tested each of the above parameters in overweight and obese individuals to determine the responsiveness of the forearm circulation to standard constrictors and dilators, and to relate the degree of vascular responsiveness to indices of obesity. Obesityrelated metabolic changes reflected in glucose, insulin and plasma lipid concentrations were also measured.
The underlying hypothesis, based on the balance of published findings, was of increased vascular reactivity reflecting heightened sympathetic neuronal activity.
METHODS

Subjects
Fourteen overweight to obese subjects (10 men and 4 women) were recruited through advertisement. Inclusion criteria were body mass index (BMI) of at least 25 kg\m#, age 65 years, absence of known metabolic disorders other than those resulting from fatness but excluding diabetes and pharmacotherapy that might affect vascular function (e.g. hormone replacement, lipid-lowering, antihypertensive and anti-inflammatory drugs) ; none smoked. The one premenopausal woman was not taking any hormonal contraceptive (F10). Supplementation with vitamins and evening primrose oil was discontinued 6 weeks before study (one subject).
The nature of the study was carefully explained and informed consent was obtained. The study had the approval of the Institution's Human Experimentation Committee. Relevant vital data are shown in Table 1 . The men and women had similar mean ages (54 and 53 years respectively). Mean BMI was 30.8p3.4 kg\m# and mean waist\hip ratio was 0.96p0.06. Only one subject drank more than 20 g of alcohol daily, up to 40 g (F1).
Experimental design
We used several standard interventions that affect blood flow and vascular resistance : noradrenaline, a vasoconstrictor acting on the muscle coat ; the vasodilators acetylcholine, acting through endothelial nitric oxide production, and nitroprusside, a nitric oxide donor ; and measurement of increased flow after transient ischaemia of the brachial artery, that acts through nitric oxide produced through shear stress.
Subjects attended for a half-day for the measurement of (1) repeated automated arm-cuff blood pressures over a 30-min period to provide a single resting, supine value for arterial pressure ; (2) total body noradrenaline spillover ; (3) forearm blood flows measured by venous occlusion plethysmography at rest, in response to a period of ischaemia, and to intra-brachial artery infusions of noradrenaline, acetylcholine and sodium nitroprusside. The subjects attended on two other days, having fasted overnight, for the taking of blood samples for plasma lipid concentrations. On the second of those days the subjects consumed a 75-g glucose drink ; plasma glucose and insulin changes were measured 0.5, 1 and 2 h later.
Forearm blood flow studies
After subjects had fasted for at least 12 h, the brachial artery was cannulated for intra-arterial blood pressure recordings. All of the drugs were infused intra-arterially at a constant infusion rate of 2 ml\min. Responses to acetylcholine (9.25, 18.5 and 37 µg\min) and to noradrenaline (25, 50 and 100 ng\min) were tested. Three doses of sodium nitroprusside (400, 800 and 1600 ng\ min) were also measured. After an equilibration period of 40 to 60 s, the average of three flow measurements before drug infusion was obtained and used as a measure of basal flow. Each drug was infused at 2 ml\min over a minimum of 2 min or until the response over three flow measurements reached a plateau (usually within 2.5 min). The average of three flow measurements at the end of the infusion period was obtained as a measure of druginduced flow. Rest periods of 5 min between doses and of 15 min between drugs were allowed. These drug concentrations had no effect on either systemic blood pressure measurement, recorded with an AE 840 physiological pressure transducer (Carlin Medical Supply P\L, Singapore), or heart rate, monitored by lead II ECG.
Since the constrictor response for the noradrenaline infusions was almost linear, we chose two parameters : the responses to the maximum dose (100 ng\min) and the area under the curve (AUC) of the combined responses to the three doses. Since the response to acetylcholine was curvilinear and almost maximal at 9.25 µg\min, we included vasodilatation recorded during the 9.25-µg\min Responses to reactive hyperaemia were also measured before drug infusions. Ischaemia was achieved by inflation of a blood pressure cuff on the upper arm to a pressure of 200 mmHg applied for 5 min.
Forearm blood flow was measured by venous occlusion plethysmography using a calibrated, alloy-filled (gallium and indium) double-strand strain gauge. 
Noradrenaline spillover rate
The principle is the dilution of tritium-labelled noradrenaline, infused at a constant rate, by endogenous noradrenaline spilling over into the circulation. This provides a neurochemical measure of ' total body ' sympathetic nervous activity. Laevo-[7-$H]noradrenaline, specific activity 12-20 Ci\mmol (New England Nuclear, Boston, MA, U.S.A.) was infused intravenously at a concentration of 0.5-1 µCi\min. At steady-state plasma-tritiated noradrenaline concentrations 45-60 min later, arterial blood was sampled through an arterial line in the opposite arm. Spillover was calculated as the infusion rate of the radiolabel divided by the plasma specific radioactivity. Full details are given elsewhere [11] . Subject F8 did not participate, leaving 13 sets of results. The coefficients of variation (55 consecutive extractions) were 5.4 % for noradrenaline mass and 7.3 % for [$H]noradrenaline.
Laboratory measurements
Plasma cholesterol, triacylglycerol and high-density lipoprotein (HDL)-cholesterol (after precipitation of non-HDL lipoproteins) were measured enzymically in a Cobas Bio analyser (Roche, Basel, Switzerland).
Anthropometric measurements
Waist circumference was measured at its smallest girth, generally at the level of umbilicus at the midpoint between the lowest rib and the iliac crest. Hip circumference was at the level of the greater trochanters. Values for waist\hip ratios regarded as ' normal ' or not indicating visceral fatness are 0.8 for women and 0.9 for men [12] . 
Statistical analysis
RESULTS
All subjects were overweight (BMI 26 kg\m#) or obese (BMI 30 kg\m#) ( Table 1) . Although two women were only marginally overweight, their waist\hip ratios were, together with the others, outside values regarded as normal for women ( 0.80). Differences between men and women for body weight were significant (P 0.01), while BMIs and waist\hip ratios were not significantly different. From the point of view of excess weight and fat distribution the 14 subjects could be considered as one group. Table 2 shows the concentrations of plasma lipids. Average plasma cholesterol, triacylglycerol and lowdensity lipoprotein (LDL)-cholesterol (calculated) concentrations were moderately raised whereas HDL-cholesterol levels were clearly low, especially in the men. Mean arterial pressures were raised ( 100 mmHg) in 10 subjects. Mean fasting plasma glucose was 4.9p 0.4 mmol\l (values for all subjects were normal) but three subjects had 2-h post-glucose levels 7.8 and 11 mmol\l, i.e. were glucose intolerant. Mean fasting 
Plasma lipid values
Basal forearm blood flow
We next examined relationships between measures of obesity and basal blood flow. The mean blood flows used in this analysis refer, in any individual, to the average of the preintervention flows. The values, expressed as ml per 100 ml of forearm, varied over a 5-fold range. Basal flows did not correlate significantly with any index of obesity.
In interpreting the effects of the interventions we used the percentage changes in flow that occurred. (Since for any individual, blood pressures did not change during the infusions, calculating resistance gives us no further information.)
The relationships between basal blood flows and the percentage increases in blood flow with both nitroprusside and post-ischaemia were significant. Figure 1 shows the response to sodium nitroprusside, 800 ng\ min : the respective correlation coefficient was k0.692 ; the correlation with the 1600-ng\min infusion was k0.718, both significant at P 0.01. The responses to nitroprusside were therefore greatest in those with the lowest basal blood flows. A similar conclusion can be drawn from the inverse relationship between basal blood flow and the percentage increase in flow after ischaemia (r l k0.67, P 0.01). Control of forearm microcirculation and body fatness The response to acetylcholine was in a similar direction, although not significant : the percentage change in flow after the 9.25-µg\min dose correlated negatively with basal flow (r l k0.52, P l 0.055). Thus all three vasodilatory procedures were most responsive in those with the lowest basal flows, i.e. in those circulations that were presumably the most preconstricted. The response was highest with nitroprusside.
The reverse was evident with intra-arterial noradrenaline, the greatest percentage changes in constriction (reduced blood flow) occurring in those with the highest basal flows (despite the theoretical confounder of decreasing drug concentration).
The correlations between both absolute and percentage delta flows and basal flows for the three doses of noradrenaline were significant ; for delta absolute flows the correlations were k0.54, k0.76 and k0.93 for 25, 50 and 100 ng\min, each being significant (P 0.05, P 0.005 and P 0.0001 respectively). Figure 2 shows the relationship of the 50-ng\min infusion with forearm basal blood flow (the higher the baseline flow, the greater the reduction in flow with noradrenaline). This suggests that the microcirculations that were least preconstricted responded most to the constrictor effect of noradrenaline.
Within the group there was also a relationship between the degree of constriction with infused noradrenaline (100 ng\min) and the degree of dilation after ischaemia (r l k0.56, P l 0.035). (Differences in forearm volume and length had a minimal effect on the above findings and therefore have not been accounted for in the correlations).
Noradrenaline kinetics
Plasma noradrenaline concentrations and total body spillover rates are shown in Table 3 .
We analysed the noradrenaline spillover data for a possible explanation for the effects of obesity on vascular responses. However, noradrenaline spillover did not correlate with any measured parameter.
There was no correlation between total body noradrenaline spillover and basal blood flow. However, spillover was inversely related to the percentage change in vasodilatation with nitroprusside (r l k0.79, P 0.001 for the 800-ng\min dose, Figure 3 ). The correlation with the 400-ng\min nitroprusside dose was also significant. This suggests that subjects with the highest prevailing total body sympathetic activity dilated least with nitroprusside.
Relationships between vascular responses and indices of body weight and obesity, and plasma lipid, glucose and insulin responses
We used percentage changes in calculated vascular resistance because blood pressures varied among the subjects. The matrix for those univariate correlations that reached statistical significance (P 0.05 or almost so) is presented in Table 4 . Also tabulated are correlations where r 0.4. Parameters of obesity, body weight, BMI and waist circumference influenced the percentage constrictor response to noradrenaline positively, but the percentage vasodilatory response to ischaemia negatively. The negative correlation between effect of low-dose acetylcholine and BMI (r l k0.53) just failed to reach statistical significance (P l 0.053). The increased vascular resistance with noradrenaline (maximum dose) was correlated significantly with body weight (r l 0.70, P l 0.005 ; Figure 4 ), waist circumference, a surrogate of visceral adiposity (r l 0.63, P l 0.022), and BMI (r l 0.64, P l 0.014). Noradrenaline areas under the curve for all doses showed similar correlations.
Waist circumference was also significantly related, but inversely, to the percentage reductions in resistance after ischaemia (r l k0.76, P l 0.002 ; Figure 5 ) and after all the nitroprusside doses. Percentage changes in vascular resistance with ischaemia also correlated inversely with BMI.
Vasodilatation post ischaemia was negatively correlated with the 120-min post-glucose insulin and possibly with the fasting insulin levels. Thus, insulin resistance (manifested by higher insulin levels) opposes vasodilatation.
Arterial pressure also influenced vasodilatation, the reduction in resistance being less as arterial pressure rose (Table 4) .
Stepwise regression analysis
Stepwise regressions were carried out with those univariate correlations that had reached or approached a 5 % level of significance or where r 0.4, beginning with the correlation with the highest level of significance and proceeding sequentially to those with less significant correlations, as shown in Table 4 . Table 5 shows those correlations that have contributed to the changes in resistance.
Increasing body weight maintained an independent association with increased resistance induced by noradrenaline which accounted for as much as 44 to 63 % of the variance. High levels of HDL-cholesterol with a small contribution from BMI maintained an independent association with acetylcholine-mediated decreases in resistance when all doses were taken into account.
Insulin resistance, represented by higher post-glucose insulin response, contributed (almost significantly) to (diminished) post-ischaemia blood flow variance.
Of the several indices of obesity, waist circumference Control of forearm microcirculation and body fatness 
DISCUSSION
The main focus of this study was to examine the potential roles of measures of adiposity and of sympathetic neuronal activity on the vascular responses to three vasodilatory agonists with differing modes of action and to the vasoconstrictor, noradrenaline. We investigated overweight to obese subjects because others had identified increased sympathetic neuronal activity in fat people that correlated with increased regional vascular resistance [6, 10] . The range of adiposity in this group enabled the exploration of vascular responses in relation to several parameters of obesity. In the absence of data on lean subjects, however, we offer no conclusion as to the specificity of these findings to obese subjects alone. However, as pointed out by others, vessel wall remodelling, such as might occur with hypertension in some of our subjects, might limit comparison with lean, normotensive subjects [1] .
Vascular responses in relation to anthropometric indices
This study demonstrated correlations between vascular functions and anthropometric indices which are consistent with the operation of increased local sympathetic neuronal activity. On univariate as well as stepwise regression analysis, body weight and BMI were correlated significantly with some indices of increased vasoconstrictor responsiveness and reduced vasodilator responsiveness in the forearm vascular bed. For instance, we found that BMI correlated with increasing vascular reactivity in response to intra-arterial noradrenaline and that vasodilatation post-ischaemia and after nitroprusside declined as waist circumference increased. The effects of both noradrenaline and nitroprusside are mediated at the level of smooth muscle in the resistance vessels : the former through sympathetic innervation, the latter by donating nitric oxide. Post-ischaemic dilation is more complex : the increased flow partly reflects the effect of adenosine on smooth muscle [13] , as well as the production of nitric oxide due to the shear stress induced by increased flow.
Our data are consistent with reported evidence for increased sympathetic nerve discharge to skeletal muscle vasculature in obese subjects [6, 8] . That the sympathetic nervous system may be overactive in obesity has reasonable support. Central body fatness is associated with increased plasma noradrenaline appearance rate [9] , and the waist\thigh ratio, an index of central adiposity, has been found to correlate with increased sympathetic neuronal activity measured by microneurography [10] . Scherrer et al. [6] reported that body fat is a major determinant of resting muscle sympathetic nerve discharge measured by microneurography in healthy men and women. About half of sympathetic activity variance was accounted for by BMI. Significantly, vascular resistance in the calf muscle was proportional to sympathetic nerve discharge to that circulation. This appears to be analogous to our observation of increased vascular resistance in the forearm circulation (reduced vasodilatation with nitroprusside) being related to noradrenaline spillover.
Nevertheless our data failed to show a correlation between noradrenaline spillover and body weight and other anthropometric measures. Systemic noradrenaline kinetics need not reflect local sympathetic neuronal outflow since different regions of the body secrete differing amounts of catecholamines. Indeed, in obesity the highest sympathetic neuronal activity may reside in the renal circulation [14] . The above data suggest that the forearm circulation is also subject to increased sympathetic neuronal responsiveness.
The vasodilatory response to temporary occlusion of the brachial artery was blunted in proportion to waist circumference in our 14 subjects ( Figure 5 ). This might also have partly reflected a degree of heightened vascular resistance, given the significant correlation between the hyperresponsiveness to infused noradrenaline and the hyporesponsiveness to post-ischaemic dilation (r l k0.56, P l 0.035), parameters related also to indices of body weight and waist circumference respectively. In the present study acetylcholine-inducible vasodilatation, generally regarded as a reliable index of endotheliumderived nitric oxide, was weakly correlated with body BMI (r l 0.53, P l 0.053 at one-dose level of infused acetylcholine). On the other hand, Steinberg et al. [15] have reported endothelial dysfunction in 12 obese subjects when compared with findings in control, leaner subjects (BMI 28 kg\m#).
Both post-ischaemic dilation and the response to nitroprusside were strongly influenced by waist circumference. Waist circumference has been put forward as an excellent simple index of visceral fat, and one that relates to future risk of coronary heart disease [16] . A recent assessment of the predictive power of various anthropometric measurements of visceral fat showed that waist circumference predicted 68 % of the variability in men whereas the power of waist\hip ratio was low [17] , although this claim requires confirmation.
A likely signal linking obesity with increased regional sympathetic neuronal activity is hyperinsulinaemia. Plasma insulin concentration has been found to be related to sympathetic neuronal activity [6] , and acute hyperinsulinaemia such as might occur diurnally in obese subjects, stimulates sympathetic nerve discharge to muscle [18, 19] . Insulin is normally a vasodilator within skeletal muscle vasculature, but this function is lost in obese subjects [20] . The vasodilatation is related to glucose transport into muscle and is partly due to endothelium-dependent release of nitric oxide [21] . The resistance to the action of insulin in obesity leads to hyperinsulinaemia and three of the present group of subjects were glucose intolerant with raised concentrations of fasting and post-glucose insulin (results not shown). Furthermore, various parameters of the glucose and insulin responses to oral glucose were negatively correlated with post-ischaemic flow although only the total insulin response contributed significantly on stepwise regression analysis (Table 5 ). More recently, leptin has been reported to link adiposity with central sympathetic nervous outflow [22] .
We also examined the possible influence of basal blood flow on the vascular responses seen in this group of overweight subjects. However, basal flow did not correlate with any anthropometric measure of adiposity. Since those with the lowest basal flows showed the greatest percentage increases in flows with nitroprusside and post-ischaemia, and those with higher flows showed the least response, the range of basal flows reflected largely the degree of vascular constriction within the microcirculation of the forearm. The inverse correlation between basal flow and increase in flow was particularly high for the nitroprusside intervention (Figure 1 ), but was also significant for the post-ischaemic response. It is possible that the weaker response to acetylcholine reflected a degree of endothelial dysfunction associated with low HDL-cholesterol or hypertension [23] [24] [25] .
On the other hand, the greatest reduction in flows with noradrenaline occurred in those circulations that were most dilated (Figure 2 ). Thus the responses to two opposing classes of agonists, the fall in noradrenalineinduced flow and the post-ischaemic rise in flow, were inversely correlated, implying that a microcirculation which is more sensitive to locally infused noradrenaline will dilate less well than one which is less sensitive. Thus, at least in this group of subjects, an intrinsic property of the microcirculation determined both increased responsiveness to a vasoconstrictor and diminished responsiveness to vasodilators. It is possible to speculate that this characteristic of the resistance vessels was amplified by additional factors that stem from increasing adiposity, including hyperinsulinaemia and hyperleptinaemia. This underlying property, likely to be a function of sympathetic neuronal activity, was also reflected in the inverse correlation between arterial pressure and the vasodilatory response to nitroprusside (Table 4) .
Our data also showed that acetylcholine-induced vascular dilation was clearly influenced by plasma lipids, especially by HDL-cholesterol (Tables 4 and 5 ). The adverse effect of hypercholesterolaemia on endotheliumdependent vasodilatation has been reported a number of times [2, 3] , as has the return to normal when the LDLcholesterol concentration is lowered [4, 5] .
Although the number of subjects was modest and heterogeneous with respect to gender, it provided a good spread of anthropometric measures (waist circumference, BMI, body weight) that revealed significant correlations with measures of vascular responsiveness and strong internal consistency. Only one woman was premenopausal (mistakenly considered perimenopausal at time of recruitment). Oestrogen is a potent vasodilator, stimulating endothelium-derived secretion of nitric oxide [26] ; nevertheless the data in this woman conformed to the overall relationships observed for the group.
In conclusion, in a group of overweight and obese subjects, the responses in the forearm microcirculation to noradrenaline and to vasodilators were influenced by several parameters of excess weight, including waist circumference, an indication of abdominal fatness, which raised the vasoconstrictive response and diminished the response to dilators. Since the increase in constriction was inversely related to at least one vasodilatory response, that to temporary ischaemia, whereas the dilatory response to nitroprusside was inversely related to the total body noradrenaline spillover rate, an index of sympathetic neuronal activity, these data, taken together, are consistent with increasing adiposity heightening sym-pathetic neuronal outflow to the microcirculation of the forearm.
